I really enjoyed making this podcast with Tom Froggatt as part of his Careers in Discovery series. anchor.fm/careers-in-dis…

Well done to Edinburgh-based biotech firm Nodus Oncology on raising £2.4 million 🤑👏 This will allow it to continue developing the next wave of cancer therapeutics in DNA damage response, while expanding its innovative portfolio 🧬📈 #BioTech #Funding ow.ly/VaEL50MLwfI

Congratulations to @#NodusOncology who have secured £2.4 million investment, the Edinburgh-based start-up will now be able to accelerate development of its #lifesciences technology Find out more via Scottish Business Insider insider.co.uk/news/nodus-onc… #StartUp #Investment #Biotech

Celebrating the successful £2.4 million raise by Nodus Oncology! Proud to announce that Cumulus Oncology is a participant in this funding round, joining new investor KHAN Technology Transfer Fund I (“KHAN-I”). #CumulusOncology #DNA #DDR #Biotech #Innovation #OncologyResearch

Cumulus Oncology is proud to be led by a team of accomplished and talented women with strong scientific backgrounds and sees it as a testament to the power of female leadership in the biotech industry! #WomenInScience #ScienceForAll #CumulusOncology #IDEA

Cumulus Oncology will be attending the LifeScienceAwardScot Awards tonight at the National Musesum of Scotland! Looking forward to seeing everyone who attends. #Event #ScottishLifeScienceAwards2023 #CumulusOncology

📢 We're excited to announce that Nikki March Land March, our Senior Director of Scientific Affairs, will be representing Cumulus Oncology at the AACR Annual Meeting 2023 in Orlando, Florida. #AACR2023 #CancerResearch #CumulusOncology

Cancer therapeutics company Cumulus Oncology has secured £9m funding from The Scottish National Investment Bank and Eos Deal Advisory insider.co.uk/news/cumulus-o…

We're thrilled to share with you all an important milestone in the Cumulus Oncology journey. We have successfully secured a further £9 million of seed investment! A huge thank you goes out to our all our investors, both existing and new. finance.yahoo.com/news/cumulus-o…